Organon & Co. (OGN) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	6.1B	6.2B	6.4B	6.3B	6.2B
Cost of Revenue	2.9B	2.9B	2.7B	2.5B	2.3B
Gross Profit	3.2B	3.4B	3.7B	3.7B	3.9B
Operating Expenses
R&D Expense	358.0M	366.0M	469.0M	528.0M	471.0M
SG&A Expense	1.7B	1.7B	1.8B	1.9B	1.7B
General & Admin Expense	—	—	1.6B	1.7B	1.4B
Selling & Marketing Expense	—	—	206.0M	209.0M	255.0M
Other Expenses	—	10.0M	—	—	—
Total Operating Expenses	2.1B	2.1B	2.2B	2.4B	2.2B
Cost and Expenses	4.9B	4.9B	4.9B	4.9B	4.5B
Operating Income (EBIT)	1.2B	1.3B	1.5B	1.3B	1.7B
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	468.0M	504.0M	520.0M	527.0M	422.0M
Net Interest Income	(468.0M)	(504.0M)	(520.0M)	(527.0M)	(422.0M)
Other Non-Op Income/Expense	(691.0M)	(860.0M)	(679.0M)	(654.0M)	(583.0M)
Non-Operating Income (excl Interest)	223.0M	356.0M	159.0M	127.0M	161.0M
EBT (Pre-Tax Income)	491.0M	425.0M	807.0M	673.0M	1.1B
Income Tax Expense	282.0M	238.0M	(57.0M)	(350.0M)	205.0M
Bottom Line
Net Income	209.0M	187.0M	864.0M	1.0B	917.0M
Earnings from Cont. Ops	209.0M	187.0M	864.0M	1.0B	917.0M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	209.0M	187.0M	864.0M	1.0B	917.0M
Per Share
Basic EPS	$0.79	$0.72	$3.36	$4.01	$3.61
Diluted EPS	$0.77	$0.72	$3.33	$3.99	$3.59
Revenue Per Share	$23.33	$23.95	$24.91	$24.54	$24.30
Shares
Basic Shares Outstanding	262.6M	259.5M	257.0M	255.2M	254.1M
Diluted Shares Outstanding	270.4M	260.8M	259.2M	256.3M	255.2M
Profitability Metrics
EBITDA	1.3B	1.3B	1.6B	1.4B	1.8B
D&A	347.0M	353.3M	277.0M	236.0M	212.0M
EBIT	959.0M	929.0M	1.3B	1.2B	1.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026